www.swisspaininstitute.ch

home

Home

home

Zurück

IMAGE Serotonin01.gif

Serotonin   home first back 1 2 3 4 5 6 7 forward

Fischer HP. Eich W. Russell IJ.

Ruprecht-Karls-Universitat Heidelberg, Medizinische Klinik und Poliklinik, Germany.

A possible role for saliva as a diagnostic fluid in patients with chronic pain. [Review] [152 refs]

Seminars in Arthritis & Rheumatism. 27(6):348-59, 1998 Jun.

Abstract:

OBJECTIVES: The focus of this review was on proteins and peptides found in saliva. Of greatest interest were those neuropeptides relevant to nociception and to the pathogenesis of chronic pain syndromes. An additional goal was to develop a standardized protocol to collect saliva for laboratory assessment. METHODS: Data were obtained through discussion with experts at the medical schools in San Antonio and Heidelberg and a Medline literature search involving all relevant studies from 1966 to 1997. The literature search was based on the following key terms: saliva, serotonin, neuropeptide, substance P (SP), calcitonin gene-related peptide (CGRP), and nerve growth factor (NGF).

RESULTS: The mean concentration of SP in the saliva of healthy normal controls ranged from 9.6 to 220 pg/mL. Generally, the concentration of SP was approximately three times higher in saliva than in plasma. In a number of painful conditions, particularly tension headache, substantial elevations of salivary SP were found. Mean values for salivary CGRP in healthy controls were approximately 22 pmol/L and were significantly elevated in patients with migraine attacks or cluster headache. There were no data to indicate prior quantitative determination of NGF in human saliva.

CONCLUSIONS: After sampling and processing techniques have been standardized, measurement of neuropeptides in human saliva could provide a valuable tool for study of patients with chronic painful disorders such as rheumatoid arthritis, osteoarthritis, and even fibromyalgia syndrome.

[References: 152]

Bardin L. Bardin M. Lavarenne J. Eschalier A.

Laboratoire de Pharmacologie Medicale, Faculte de Medecine, Clermont-Ferrand, France.

Effect of intrathecal serotonin on nociception in rats: influence of the pain test used.

Experimental Brain Research. 113(1):81-7, 1997 Jan.

Abstract

The involvement of serotonin (5-HT) in the modulation of nociceptive impulse in the spinal cord has been widely studied. However, its activity, considering the nature of noxious stimuli and the type of 5-HT receptors involved, merits to be further elucidated.

The present behavioural study was performed to compare the dose-antinociceptive effect relationship of 5-HT in rats, after intrathecal (i.t.) injection (10 microliters/rat), using mechanical (paw pressure), thermal (tail immersion and tail-flick) and chemical (formalin) pain tests. In rats submitted to the paw pressure test, 5-HT was found to possess a dose-dependent antinociceptive activity (0.01, 0.1, 1, 10 and 20 micrograms/rat) when vocalization threshold was assessed as a pain parameter. A peak effect occurred 5min after the injection and the effect was maintained for 45 min. The lowest active dose was 0.1 microgram (maximum increase in vocalization thresholds, 23 +/- 3%) and a plateau was observed for 10 micrograms and 20 micrograms (maximum increase in vocalization thresholds, 72 +/- 7% and 71 +/- 6%, respectively).

When paw withdrawal was assessed, 5-HT induced a weak hyperalgesic effect for the highest dose (60 micrograms), while other doses were ineffective. In the tail-immersion (warmth and cold) and tail-flick tests, different doses (0.01, 0.1, 1, 10, 30, 60 and 100 micrograms/rat) were studied. In the two immersion tests, only the highest doses (60 micrograms and 100 micrograms) significantly increased the withdrawal thresholds from 5 to 45 min after the injection. The maximum effect was observed at 5 min (23 +/- 4% and 21 +/- 6% for 60 micrograms; 27 +/- 3% and 30 +/- 6% for 100 micrograms in the warmth and cold immersion test, respectively).

In the tail-flick test, the doses of 30, 60 and 100 micrograms/rat dose-dependently and significantly increased the withdrawal thresholds from 5 to 45 min after the injection, with a maximum effect at 5 min (30 +/- 5% for 30 micrograms; 37 +/- 6% for 60 micrograms; and 45 +/- 4% for 100 micrograms). In the formalin test, 5-HT (10, 25, 50, 75 and 100 micrograms/rat) produced dose-related antinociception.

(Forts.)forward

Design: © 2002 MedConsulting Dr. A. U. Freiburghaus, CH-8712 Stäfa, Switzerland, Kontakt
Inhalt/contents: © 2002 Dr. med.
Hermann L. Keller, ZASA, Hauptstr. 81, Muttenz, Schweiz

Haftungsausschluss/Disclaimer
Webmaster: MedConsulting Dr. A.U. Freiburghaus, +41(0)1-796 42 10

Bei technischen Problemen oder für Anregungen
kontaktieren Sie bitte unseren Webmaster  

for technical issues or general comments
please
contact our webmaster

Letzte Änderung am 16.1.2004 um 14:29:31 Uhr